These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 354591)

  • 21. Efficacy of cefminox compared with amoxicillin/clavulanic acid as a single dose for the prevention of intra-abdominal sepsis in mice intraperitoneally infected with different strains of Escherichia coli and one strain of Bacteroides fragilis.
    Huelves L; Gracia M; Del Prado G; Rodríguez-Cerrato V; Martínez-Marín C; Ponte C; Soriano F; Coronel P; Gimeno M; Blanco J
    Int J Antimicrob Agents; 2006 Aug; 28(2):151-3. PubMed ID: 16815688
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice.
    Thadepalli H; Chuah SK; Gollapudi S
    Chemotherapy; 2004 Jun; 50(2):76-80. PubMed ID: 15211081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of pefloxacin in comparison to gentamicin in the treatment of experimentally induced peritonitis in rats.
    Nord CE; Edlund C; Lahnborg G
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():59-63. PubMed ID: 2872197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reciprocal synergy between Escherichia coli and Bacteroides fragilis in an intra-abdominal infection model.
    Rotstein OD; Kao J; Houston K
    J Med Microbiol; 1989 Aug; 29(4):269-76. PubMed ID: 2668529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A peritonitis model with low mortality and persisting intra-abdominal abscesses.
    Buyne OR; Bleichrodt RP; Verweij PE; Groenewoud HM; van Goor H; Hendriks T
    Int J Exp Pathol; 2006 Oct; 87(5):361-8. PubMed ID: 16965563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacteriology and antibiotic susceptibility of community-acquired intra-abdominal infection in children.
    Lin WJ; Lo WT; Chu CC; Chu ML; Wang CC
    J Microbiol Immunol Infect; 2006 Jun; 39(3):249-54. PubMed ID: 16783457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis.
    Tzianabos AO; Kasper DL; Cisneros RL; Smith RS; Onderdonk AB
    J Clin Invest; 1995 Dec; 96(6):2727-31. PubMed ID: 8675640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aerobic and anaerobic microbiology of intra-abdominal abscesses in children.
    Brook I
    South Med J; 1989 Dec; 82(12):1479-82. PubMed ID: 2688128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983.
    Nord CE; Olsson-Liljequist B
    Scand J Infect Dis Suppl; 1984; 43():44-9. PubMed ID: 6100139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Manipulation of the size and clone of an intra-abdominal abscess in rats.
    Nakatani T; Sato T; Trump BF; Siegel JH; Kobayashi K
    Res Exp Med (Berl); 1996; 196(2):117-26. PubMed ID: 8739801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro susceptibility of anaerobes: comparison of clindamycin and other antimicrobial agents.
    Sutter VL
    J Infect Dis; 1977 Mar; 135 Suppl():S7-12. PubMed ID: 850095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Animal models for intra-abdominal infection.
    Sayek I
    Hepatogastroenterology; 1997; 44(16):923-6. PubMed ID: 9261579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of Candida albicans in the pathogenesis of experimental fungal/bacterial peritonitis and abscess formation.
    Sawyer RG; Adams RB; Rosenlof LK; May AK; Pruett TL
    Am Surg; 1995 Aug; 61(8):726-31. PubMed ID: 7618816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental animal models for anaerobic infections.
    Onderdonk AB; Kasper DL; Mansheim BJ; Louie TJ; Gorbach SL; Bartlett JG
    Rev Infect Dis; 1979; 1(2):291-301. PubMed ID: 232936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models.
    Giacometti A; Ghiselli R; Cirioni O; Mocchegiani F; D'Amato G; Orlando F; Sisti V; Kamysz W; Silvestri C; Naldoski P; Lukasiak J; Saba V; Scalise G
    J Antimicrob Chemother; 2004 Sep; 54(3):654-60. PubMed ID: 15294887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gentamycin reduces bacteremia and mortality rates associated with the treatment of experimental peritonitis with recombinant tissue plasminogen activator.
    van Goor H; de Graaf JS; Kooi K; Bleichrodt RP
    J Am Coll Surg; 1995 Jul; 181(1):38-42. PubMed ID: 7599769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal bacteria translocate into experimental intra-abdominal abscesses.
    Wells CL; Rotstein OD; Pruett TL; Simmons RL
    Arch Surg; 1986 Jan; 121(1):102-7. PubMed ID: 3510604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis.
    Montravers P; Andremont A; Massias L; Carbon C
    J Infect Dis; 1994 Apr; 169(4):821-30. PubMed ID: 8133097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vivo bactericidal activity of Sch 34343 in Bacteroides fragilis abscesses and in Bacteroides fragilis-Escherichia coli abscesses.
    Wells CL; Arland LA; Simmons RL; Rotstein OD
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():199-206. PubMed ID: 3897172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic efficacy and pharmacokinetic properties of ciprofloxacin in intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.
    Fu KP; Vince T; Bloom R; Gregory FJ; Hung PP
    Drugs Exp Clin Res; 1987; 13(8):493-6. PubMed ID: 3322752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.